Bero, L. A. & Rennie, D. (1996) Influences on the quality of published drug trials. International Journal of Technology Assessment in Healthcare, 12, 209–237.
Blumenthal, D., Campbell, E., Anderson, M., et al (1997) Withholding research results in academic life science: evidence from a national survey of faculty. JAMA, 277, 1224–1228.
Davidson, R. A. (1986) Source of funding and outcome of clinical trials. Journal of General Internal Medicine, 1, 155–158.
Freemantle, N., Anderson, I. & Young, P. (2000) Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Metaregression analysis. British Journal of Psychiatry, 177, 292–302.
Friedberg, M., Saffran, B., Stinson, T., et al (1999) Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA, 282, 1453–1457.
Gøtzsche, P. C. (1989) Multiple publication of reports of drug trials. European Journal of Clinical Pharmacology, 36, 429–432.
Henderson, C., Howard, L. & Wilkinson, G. (2003) Acknowledgement of psychiatric research funding. British Journal of Psychiatry, 183, 273–275.
Huston, P. & Moher, D. (1996) Redundancy, disaggregation, and the integrity of medical research. Lancet, 347, 1024–1026.
Johansen, H. & Gøtzsche, P. (1999) Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA, 282, 1752–1759.
Kjaergard, L. L. & Als-Nielsen, B. (2002) Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ, 325, 249–253.
Lewison, G., Dawson, G. & Anderson, J. (1995) The behaviour of biomedical scientific authors in acknowledging their funding sources. Proceedings of Fifth International Conference of the International Society for Scientometrics and Informetrics, pp. 255–264. Medford, NJ: Learned Information.
Moncrieff, J. (2003) Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. British Journal of Psychiatry, 183, 161–166.
Nathan, D. G. & Weatherall, D. J. (1999) Academia and industry: lessons from the unfortunate events in Toronto. Lancet, 353, 771–772.
Rennie, D. (1997) Thyroid storm. JAMA, 277, 1238–1243.
Rochon, P. A., Gurwitz, J. H., Simms, R., et al (1994) A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Archives of Internal Medicine, 154, 157–163.
Safer, D. J. (2002) Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. Journal of Nervous and Mental Disease, 190, 583–592.
Scally, G. & Donaldson, L. J. (1998) The NHS's 50 anniversary. Clinical governance and the drive for quality improvement in the new NHS in England. BMJ, 317, 61–65.
Smith, R. (2001) Journals fail to adhere to guidelines on conflict of interest. BMJ, 323, 651.
Wahlbeck, K. & Adams, C. (1999) Beyond conflict of interest. Sponsored drug trials show more favourable outcomes. BMJ, 318, 465.
Yaphe, J., Richard, E., Knishkowy, B., et al (2001) The association between funding by commercial interests and study outcome in randomized controlled drug trials. Family Practice, 18, 565–568.